With trade tiffs, earnings reports, and politics largely dominating the more visible areas of the stock market, it’s important for investors to divert their attention to the smaller, often overlooked companies every once in a while. When it comes to overlooked companies, no type of equity falls more into that category than penny stocks. So […]
Read MoreMatinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making […]
Read MoreWhen it comes to identifying stocks that might make useful investments, there are as many strategies as there are people. You can break these strategies into any different number of categories. I like to differentiate between strategies by thinking first about the amount of time I might actually plan to hold the stock in question, […]
Read MorevTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates worldwide. The company’s drug candidates comprise azeliragon (TTP488), an orally administered, small molecule antagonist targeting the receptor for advanced glycation endproducts, which is in Phase III clinical trials for the treatment of Alzheimer’s disease. Annual EPS Growth – Companies […]
Read MoreUnder Armour Inc. (UA) released its financials for Q4 2018 before the bell Tuesday, and investors acted surprisingly fickle over the better-than-expected results. Shares of the fitness apparel company constantly whipsawed into the red and black during the session before eventually ending the day as one of the S&P 500’s top gainers. Despite Under Amour’s […]
Read More